Despite being backed by a significant budget and the marketing power of a major technology company, IBM Watson appears to be falling short of expectations when it comes to revolutionizing cancer care.

IBM is stopping development and sales of its tool that utilizes Watson AI to help pharmaceutical companies find new drugs, according to a STAT report. A source told STAT that the product, Watson for ...

Now that IBM has sold its Portal, Commerce, Notes and Domino on-premises offerings to HCL Technologies, it seems that Big Blue is pushing its chips into the center of the table on IBM Watson and the ...

IBM announced today that is has teamed with the Toronto Raptors to bring cognitive analysis in the form of IBM Watson to the NBA team’s talent evaluation process. The new tool called IBM Sports ...

The use of artificial intelligence technology in clinical decision making is still in an early phase. But recent studies indicate that AI has the potential to help improve the way clinicians treat ...

In a chic Manhattan office building, around 600 people work on the future. It's the global headquarters of IBM Watson, the cognitive technology that the company says "can think like a human." You may ...

IBM’s Watson unit is receiving heat today in the form of a scathing equity research report from Jefferies’ James Kisner. The group believes that IBM’s investment into Watson will struggle to return ...